Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| AMGN | Amgen, Inc. | 1.46% | 243.82 | 1.3% | $795.90m | |
| IMMU | Immunomedics, Inc. | 0.07% | 85.36 | 11.0% | $697.18m | |
| MRNA | Moderna, Inc. | 6.60% | 69.47 | 0.0% | $666.49m | |
| NVAX | Novavax, Inc. | 10.86% | 113.56 | 96.5% | $629.01m | |
| ILMN | Illumina, Inc. | 4.74% | 299.89 | 3.5% | $582.79m | |
| GILD | Gilead Sciences, Inc. | 0.00% | 62.25 | 1.0% | $574.11m | |
| REGN | Regeneron Pharmaceuticals, Inc. | 2.98% | 574.06 | 2.7% | $443.39m | |
| VRTX | Vertex Pharmaceuticals, Inc. | 1.92% | 268.18 | 1.9% | $340.86m | |
| BIIB | Biogen, Inc. | 1.20% | 273.28 | 1.6% | $334.97m | |
| ALXN | Alexion Pharmaceuticals, Inc. | 2.15% | 114.43 | 2.0% | $285.22m | |
| EXAS | EXACT Sciences Corp. | 3.60% | 97.70 | 20.7% | $257.29m | |
| SRNE | Sorrento Therapeutics, Inc. | 4.84% | 9.64 | 1.5% | $240.99m | |
| VXRT | Vaxart, Inc. | 7.40% | 7.40 | 0.0% | $213.88m | |
| SGEN | Seattle Genetics, Inc. | 3.08% | 184.95 | 6.0% | $212.14m | |
| MNTA | Momenta Pharmaceuticals, Inc. | 0.02% | 52.40 | 3.0% | $193.58m |
Company Profile
CRISPR Therapeutics AG engages in the development and commercialization of therapies derived from genome-editing technology. Its proprietary platform CRISPR/Cas9-based therapeutics allows for precise and directed changes to genomic DNA. The company was founded by Rodger Novak, Emmanuelle Charpentier, Shaun Patrick Foy, Matthew Porteus, Daniel Anderson, Chad Cowan and Craig Mellow in 2014 and is headquartered in Zug, Switzerland.